1. Home
  2. WS vs HCM Comparison

WS vs HCM Comparison

Compare WS & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

SELL

Current Price

$37.52

Market Cap

2.0B

Sector

N/A

ML Signal

SELL

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

SELL

Current Price

$14.41

Market Cap

2.3B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WS
HCM
Founded
1955
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.3B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
WS
HCM
Price
$37.52
$14.41
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $21.14
AVG Volume (30 Days)
★ 328.4K
38.4K
Earning Date
12-16-2026
07-30-2026
Dividend Yield
★ 1.74%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,443,800,000.00
N/A
Revenue This Year
$11.55
$14.11
Revenue Next Year
$0.38
$11.97
P/E Ratio
★ N/A
$5.49
Revenue Growth
★ 11.33
N/A
52 Week Low
$27.22
$9.77
52 Week High
$49.17
$16.33

Technical Indicators

Market Signals
Indicator
WS
HCM
Relative Strength Index (RSI) 44.40 50.59
Support Level $36.04 $13.00
Resistance Level $39.42 $14.44
Average True Range (ATR) 2.38 0.36
MACD -0.48 0.03
Stochastic Oscillator 18.51 54.07

Price Performance

Historical Comparison
WS
HCM

About WS Worthington Steel Inc.

Worthington Steel Inc is a value-added metals processors with the ability to provide a diversified products and services that span a variety of end markets. It is a value-added processor of carbon flat-rolled steel and a producer of laser welded solutions and electrical steel laminations. It is one of the independent intermediate processors of carbon flat-rolled steel in the U.S. It occupy a niche in the steel industry by focusing on products requiring exact specifications. The company has one operating and reportable segment. It has presence in United States, Canada, Mexico, and Rest of world. The company has majority of sales from United States.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: